Dr. Akihiko Suto Brystkræftkirurgi


Konsulent - Brystkræft kirurgi , Erfaring:

Bog Aftale

Om læge

Dr. Akihiko Suto er den bedste brystkræftkirurg i Tokyo, Japan.

Dr. Akihiko Suto er tilknyttet National Cancer Center Hospital, Japan.

The Department of Breast Surgery consisting of five staff surgeons specialized in breast cancer (Dr. Kinoshita, Dr. Takayama, Dr. Jimbo, Dr. Shiino, and Dr. Murata), one chief resident (Dr. Watase), and two or three rotating residents, deals with treatment of breast disease through surgeries, as well as diagnosis of breast diseases and assessment of lymph nodes in the axillary and clavicular regions which are suspected harboring metastases. In 2018 fiscal year, we performed a total of 894 operations of breast diseases (770 was primary breast cancer or breast sarkom). The number of patients we have treated is increasing year by year, and 2018 treated patients number was the highest ever in our department. The trend of surgical procedure also has been changing in recent years. Although breast partial resection (Bp) accounted for 39% of the total surgeries in our department in 2018, and the Bp rate has been constant. On the other hand, immediate reconstruction surgeries have overwhelmingly increased in recent years. A total of 172 immediate breast reconstructions were performed in 2018 fiscal year, comprising 22% of all cases. The rate of mastectomy was 477 cases (60%), including 172 cases of immediate reconstruction. SLNB was performed in 578 (78%) patients, and many patients were spared from ALND in 2018.

Hospital

National Cancer Center, Japan

specialisering

  • Brystkræftkirurgi

Procedurer udført

  • Brystkræftkirurgi
  • mastektomi
  • Delvis mastektomi
  • Radikal mastektomi

Forskning og publikationer

Brug for hjælp? Vores team er klar til at hjælpe dig.

Vi ønsker en hurtig bedring af din kære og nær en.

×
Start chat
Vi er online! Chat med os!
Scan koden
Hej,

Velkommen til CancerFax!

CancerFax er en banebrydende platform dedikeret til at forbinde individer, der står over for kræft i avanceret stadie, med banebrydende celleterapier som CAR T-Cell-terapi, TIL-terapi og kliniske forsøg verden over.

Fortæl os, hvad vi kan gøre for dig.

1) Kræftbehandling i udlandet?
2) CAR T-Cell terapi
3) Kræftvaccine
4) Online videokonsultation
5) Protonterapi